Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human umbilical cord mesenchymal stem cell type II
- Development stage
- Unknown
- Lead developer
- Zhejiang Wolwo Stem Cell Technology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
human umbilical cord mesenchymal stem cell type II is an investigational allogeneic cell therapy consisting of human umbilical cord-derived mesenchymal stem cells (MSCs). Developed by Zhejiang Wolwo Stem Cell Technology, a subsidiary of Zhejiang Wolwo Biopharmaceutical (WOLWOPHARMA), the therapy is designed to leverage the immunomodulatory, anti-inflammatory, and tissue-repair properties of MSCs. It is being developed for the treatment of sepsis and septic shock, aiming to mitigate the life-threatening cytokine storm and organ dysfunction associated with these conditions. In October 2026, China's National Medical Products Administration (NMPA) approved the initiation of Phase I/II/III clinical trials for this indication.
- Other names
- human umbilical cord mesenchymal stem cell type II injectionhuman umbilical cord-derived mesenchymal stem cell type II injection人脐带间充质干细胞II型注射液
Beyond the preview
Go deeper on human umbilical cord mesenchymal stem cell type II.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human umbilical cord mesenchymal stem cell type II.